The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

A Minnesota task force advising lawmakers on psychedelic medicine policy has recommended decriminalizing psilocybin mushrooms ...

Only a few patients have undergone an intensive gene therapy cure for sickle cell disease since it was approved by the FDA ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

Hanx Biopharmaceuticals has dosed the first subject in a trial of HX044, a bispecific antibody designed for advanced solid tumours.

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...

New model and vector could be instrumental in transforming the lives of XLSA patients and those with a broad spectrum of other diseases PHILADELPHIA, Jan. 2, 2025 /PRNewswire/ -- Researchers at ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

In a significant advancement for cancer care, the U.S. Food and Drug Administration (FDA) has approved an injectable version ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication. It uses a ...